I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of MAGEE1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 2784.71 | 2615 / 2642 | 95% | 20.51 | 673 / 705 |
| thymus | 96% | 392.66 | 626 / 653 | 98% | 7.99 | 594 / 605 |
| prostate | 95% | 355.60 | 232 / 245 | 95% | 8.77 | 478 / 502 |
| adrenal gland | 90% | 379.68 | 231 / 258 | 94% | 15.96 | 216 / 230 |
| ovary | 96% | 469.93 | 172 / 180 | 81% | 4.53 | 349 / 430 |
| breast | 81% | 295.32 | 374 / 459 | 94% | 8.26 | 1049 / 1118 |
| kidney | 72% | 211.81 | 64 / 89 | 90% | 5.11 | 814 / 901 |
| pancreas | 80% | 219.87 | 264 / 328 | 78% | 4.03 | 138 / 178 |
| uterus | 97% | 569.24 | 165 / 170 | 59% | 3.81 | 269 / 459 |
| skin | 83% | 255.36 | 1507 / 1809 | 67% | 3.96 | 317 / 472 |
| bladder | 90% | 363.33 | 19 / 21 | 55% | 2.55 | 279 / 504 |
| lung | 48% | 121.03 | 280 / 578 | 71% | 3.75 | 815 / 1155 |
| esophagus | 72% | 257.78 | 1044 / 1445 | 42% | 2.19 | 77 / 183 |
| intestine | 75% | 297.62 | 728 / 966 | 25% | 1.05 | 134 / 527 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.16 | 1 / 1 |
| spleen | 99% | 373.20 | 238 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 626.29 | 1311 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 90% | 4.49 | 72 / 80 |
| stomach | 54% | 181.98 | 195 / 359 | 35% | 1.60 | 100 / 286 |
| adipose | 71% | 220.30 | 854 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 3.12 | 30 / 45 |
| heart | 57% | 178.63 | 492 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 2.50 | 16 / 29 |
| liver | 0% | 0 | 0 / 226 | 22% | 0.94 | 89 / 406 |
| peripheral blood | 16% | 41.39 | 149 / 929 | 0% | 0 | 0 / 0 |
| muscle | 4% | 9.26 | 35 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0008150 | Biological process | biological_process |
| GO_0030425 | Cellular component | dendrite |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MAGEE1 |
| Protein name | Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen) MAGEE1 protein |
| Synonyms | KIAA1587 HCA1 |
| Description | FUNCTION: May enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. . |
| Accessions | Q6IAI7 Q9HCI5 ENST00000361470.4 |
